Paper2017529
Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders?
Elia J and 3 others. Psychiatry Res, 1991. Cited by 209 papers, by iCite.
Cite this record
ConductScience Library. Methylphenidate and dextroamphetamine treatments of hyperactivity: are there true nonresponders? Papers, record 2017529. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2017529
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Attention Deficit Disorder with Hyperactivity | Major topic |
| Dextroamphetamine | Major topic |
| Methylphenidate | Major topic |
| Analysis of Variance | |
| Child | |
| Day Care, Medical | |
| Double-Blind Method | |
| Humans | |
| Male | |
| Placebos | |
| Research Design |
Source PubMed
Cited by58
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 209 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42415397 | A Randomised Open-Label Comparison of Dexamphetamine and Methylphenidate in Children With Attention Deficit Hyperactivity Disorder (ADHD): Symptom Response, Adherence and Weight Impact Over 12 Months. | J Paediatr Child Health | 2026 | https://conductscience.org/library/papers/42415397 | PubMed |
| 36971690 | Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). | Cochrane Database Syst Rev | 2023 | https://conductscience.org/library/papers/36971690 | PubMed |
| 36226261 | Neuroprotection in late life attention-deficit/hyperactivity disorder: A review of pharmacotherapy and phenotype across the lifespan. | Front Hum Neurosci | 2022 | https://conductscience.org/library/papers/36226261 | PubMed |
| 35201607 | Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults. | Cochrane Database Syst Rev | 2022 | https://conductscience.org/library/papers/35201607 | PubMed |
| 33928056 | Effectiveness and safety of dexamphetamine sulfate (Attentin®) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study. | Scand J Child Adolesc Psychiatr Psychol | 2021 | https://conductscience.org/library/papers/33928056 | PubMed |
| 33495438 | Altered dopaminergic firing pattern and novelty response underlie ADHD-like behavior of SorCS2-deficient mice. | Transl Psychiatry | 2021 | https://conductscience.org/library/papers/33495438 | PubMed |
| 32794136 | Is Methylphenidate Beneficial and Safe in Pharmacological Cognitive Enhancement? | CNS Drugs | 2020 | https://conductscience.org/library/papers/32794136 | PubMed |
| 31455722 | Genetic Signatures of Drug Response Variability in Drosophila melanogaster. | Genetics | 2019 | https://conductscience.org/library/papers/31455722 | PubMed |
| 31122010 | Effect of omega-3 plus methylphenidate as an alternative therapy to reduce attention deficit-hyperactivity disorder in children. | Korean J Pediatr | 2019 | https://conductscience.org/library/papers/31122010 | PubMed |
| 27520752 | Central Stimulant Treatment of Childhood Attention Deficit Hyperactivity Disorder : Issues and Recommendations from a US Perspective. | CNS Drugs | 1997 | https://conductscience.org/library/papers/27520752 | PubMed |
| 27460004 | Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial. | BMC Psychiatry | 2016 | https://conductscience.org/library/papers/27460004 | PubMed |
| 27453079 | Combined Stimulant and Guanfacine Administration in Attention-Deficit/Hyperactivity Disorder: A Controlled, Comparative Study. | J Am Acad Child Adolesc Psychiatry | 2016 | https://conductscience.org/library/papers/27453079 | PubMed |
| 26844979 | Amphetamines for attention deficit hyperactivity disorder (ADHD) in children and adolescents. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/26844979 | PubMed |
| 26599576 | Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD). | Cochrane Database Syst Rev | 2015 | https://conductscience.org/library/papers/26599576 | PubMed |
| 26587055 | Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical Care Pathway. | Child Adolesc Psychiatry Ment Health | 2015 | https://conductscience.org/library/papers/26587055 | PubMed |
| 25378930 | Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial. | Neuropsychiatr Dis Treat | 2014 | https://conductscience.org/library/papers/25378930 | PubMed |
| 24813374 | Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder. | J Child Adolesc Psychopharmacol | 2014 | https://conductscience.org/library/papers/24813374 | PubMed |
| 24666268 | Minimizing adverse events while maintaining clinical improvement in a pediatric attention-deficit/hyperactivity disorder crossover trial with dextroamphetamine and methylphenidate. | J Child Adolesc Psychopharmacol | 2014 | https://conductscience.org/library/papers/24666268 | PubMed |
| 23681505 | Efficacy and safety of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder and recent methylphenidate use. | Adv Ther | 2013 | https://conductscience.org/library/papers/23681505 | PubMed |
| 23659360 | Clinical gains from including both dextroamphetamine and methylphenidate in stimulant trials. | J Child Adolesc Psychopharmacol | 2013 | https://conductscience.org/library/papers/23659360 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2017529
GET https://conductscience.org/api/papers/v1/2017529/cited_by?page=2